Leadership Overview
Roche has 10 executives leading key functions including strategy, technology, operations, and finance.
Driven by a commitment to scientific advancement, Roche is dedicated to improving people's lives through innovative healthcare solutions, pioneering personalized healthcare and targeted therapies.
Driven by a commitment to scientific advancement, Roche is dedicated to improving people's lives through innovative healthcare solutions, pioneering personalized healthcare and targeted therapies.
Leadership Roles at Roche
Brigitte Nolet - President & Chief Executive Officer, Roche Pharmaceuticals (Canada)
Brigitte Nolet, the President & Chief Executive Officer, Roche Pharmaceuticals (Canada) at Roche, directs the strategic growth and operational execution of the pharmaceutical division within the Canadian market. Overseeing all commercial activities, Brigitte Nolet ensures the delivery of innovative medicines to patients across Canada, focusing on key therapeutic areas such as oncology and immunology. This leadership role involves fostering strong relationships with healthcare providers, regulatory bodies, and patient advocacy groups to advance Roche's mission. Nolet's strategic vision drives market penetration and ensures access to life-changing treatments, aligning Canadian operations with global pharmaceutical objectives. The President & Chief Executive Officer, Roche Pharmaceuticals (Canada) champions Roche's commitment to personalized healthcare by facilitating the adoption of targeted therapies and companion diagnostics. Nolet's leadership significantly impacts patient care and reinforces Roche's position as a leader in Canadian healthcare innovation.
Avi Danziger - Chief Executive Officer, Roche (Israel)
Avi Danziger, the Chief Executive Officer, Roche (Israel) at Roche, spearheads the company's strategic direction and operational management within Israel. Overseeing both pharmaceutical and diagnostic operations, Avi Danziger drives market leadership and ensures the delivery of advanced healthcare solutions to the Israeli population. This executive position involves cultivating key partnerships with local healthcare institutions and government agencies to expand access to Roche's innovative treatments and diagnostic tools. Danziger's leadership focuses on advancing personalized healthcare initiatives tailored to the specific needs of the region. The Chief Executive Officer, Roche (Israel) plays a pivotal role in translating Roche's global mission into tangible outcomes, enhancing patient care and contributing to the nation's health sector. Danziger's strategic oversight is crucial for navigating the local market dynamics and reinforcing Roche's commitment to improving lives through science.
Maria del Pilar Camacho - Director, Finance & Administrative & Chief Financial Officer
Maria del Pilar Camacho, the Director, Finance & Administrative & Chief Financial Officer at Roche, oversees the financial health and administrative functions of the organization. Directing all financial planning, reporting, and investment strategies, Maria del Pilar Camacho ensures fiscal responsibility and supports sustainable growth across Roche's pharmaceutical and diagnostic divisions. This comprehensive role involves managing budgets, optimizing resource allocation, and ensuring compliance with financial regulations. Camacho's leadership is crucial for funding research and development initiatives, enabling Roche to pursue groundbreaking scientific advancements. The Director, Finance & Administrative & Chief Financial Officer plays a vital part in safeguarding the company's financial stability and driving value creation. Camacho's strategic financial management directly supports Roche's mission to improve people's lives through innovative healthcare solutions.
Tin Ha - Chief Financial Officer (China)
Tin Ha, the Chief Financial Officer (China) at Roche, directs financial strategy and operations within the significant Chinese market. Overseeing all fiscal activities, Tin Ha ensures robust financial planning, accurate reporting, and strategic investment to support Roche's pharmaceutical and diagnostic growth in China. This executive role involves managing regional financial performance, optimizing resource allocation, and ensuring adherence to local and global financial regulations. Ha's leadership is critical for driving profitability and enabling the expansion of innovative healthcare solutions to Chinese patients. The Chief Financial Officer (China) plays a pivotal role in translating Roche's global financial objectives into regional success, supporting the company's mission to improve lives. Ha's financial acumen is essential for navigating the dynamic Chinese market and reinforcing Roche's commitment to scientific advancement.
Farhan Bhatti - Chief Financial Officer & Director, Finance
Farhan Bhatti, the Chief Financial Officer & Director, Finance at Roche, leads the financial operations and strategic fiscal planning for the organization. Directing all aspects of financial management, Farhan Bhatti ensures the company's financial integrity and supports its ambitious goals in pharmaceuticals and diagnostics. This role encompasses budgeting, forecasting, risk management, and capital allocation, driving efficiency and profitability. Bhatti's strategic financial guidance is essential for funding critical research and development projects, enabling Roche to pioneer new treatments and diagnostic tools. The Chief Financial Officer & Director, Finance plays a key part in optimizing financial performance and ensuring the sustainable expansion of Roche's global reach. Bhatti's expertise directly contributes to Roche's mission of advancing science to improve people's lives.
Rajendra Dubey - Chief Operating Officer, MH and Punjab Cluster
Rajendra Dubey, the Chief Operating Officer, MH and Punjab Cluster at Roche, directs operational strategies and execution within the specified regions. Overseeing the integrated operations of pharmaceuticals and diagnostics, Rajendra Dubey ensures efficient service delivery and market responsiveness. This leadership role involves optimizing supply chains, managing regional resources, and driving operational excellence to meet the healthcare needs of the MH and Punjab clusters. Dubey's focus is on enhancing accessibility to Roche's innovative solutions, supporting the company's commitment to improving patient outcomes. The Chief Operating Officer, MH and Punjab Cluster plays a key part in translating global strategies into localized operational success, ensuring seamless integration of diagnostic and pharmaceutical services. Dubey's operational acumen is critical for achieving business objectives and reinforcing Roche's presence in these key markets.
Mia Zhao - Chief of Staff
Mia Zhao, the Chief of Staff at Roche, directs strategic initiatives and operational alignment across key departments. Overseeing critical projects, Mia Zhao ensures seamless execution of the company's global strategy in pharmaceuticals and diagnostics. This leadership position involves coordinating cross-functional teams to drive innovation and maintain Roche's pioneering position in healthcare. By managing internal communications and stakeholder engagement, Mia Zhao facilitates efficient decision-making and supports the executive leadership team in achieving ambitious growth targets. The role demands a deep understanding of Roche's dual focus on developing life-saving medicines and advanced diagnostic tools, ensuring operational excellence supports scientific breakthroughs. Zhao's efforts directly contribute to the company's mission of advancing science to improve patient outcomes worldwide.
Robert McRuer - Chief Technology Officer
Robert McRuer, the Chief Technology Officer at Roche, architects the company's technological vision and digital transformation. Overseeing all aspects of IT infrastructure and innovation, Robert McRuer drives the integration of cutting-edge technologies across both the pharmaceuticals and diagnostics divisions. This critical role involves developing and implementing robust cybersecurity measures, managing data analytics platforms, and fostering a culture of technological advancement. McRuer's leadership ensures that Roche leverages digital tools to accelerate drug discovery, enhance diagnostic accuracy, and optimize operational efficiency. By championing new technological solutions, the Chief Technology Officer directly supports Roche's commitment to personalized healthcare and its mission to improve people's lives through science. McRuer's strategic direction is vital for maintaining Roche's competitive edge in a rapidly evolving global market.
John Pascual - Global Chief Marketing Officer & Site Manager
John Pascual, the Global Chief Marketing Officer & Site Manager at Roche, orchestrates global marketing strategies and oversees site operations to drive market penetration and brand leadership. Directing all marketing initiatives, John Pascual ensures the effective communication of Roche's innovative pharmaceutical and diagnostic solutions to healthcare professionals and patients worldwide. This dual role involves managing brand positioning, product launches, and market development, while also ensuring the efficient functioning of the designated site. Pascual's leadership focuses on translating scientific advancements into compelling market narratives that highlight Roche's commitment to personalized healthcare. The Global Chief Marketing Officer & Site Manager champions customer-centric approaches, driving demand and reinforcing Roche's reputation for excellence. Pascual's strategic oversight is essential for maximizing commercial impact and supporting the company's overarching mission to improve lives.
Rebecca Laurin - Governance & Strategic Alignment Leader & Chief of Staff
Rebecca Laurin, the Governance & Strategic Alignment Leader & Chief of Staff at Roche, ensures robust corporate governance and facilitates strategic alignment across global operations. Overseeing critical governance frameworks, Rebecca Laurin supports the executive team in maintaining compliance and ethical standards, crucial for Roche's pharmaceutical and diagnostic endeavors. This leadership position involves translating strategic objectives into actionable plans, ensuring all divisions work cohesively towards common goals. Laurin's role is instrumental in enhancing organizational efficiency and fostering a culture of accountability. By driving strategic alignment, the Governance & Strategic Alignment Leader & Chief of Staff directly contributes to the successful execution of Roche's mission to advance science and improve patient lives. Laurin's expertise is vital for navigating complex regulatory landscapes and ensuring sustainable growth.
Explore Leadership Teams in Manufacturing
Founded in 1891 and headquartered in Rahway, NJ, Merck & Co., Inc. is a global healthcare company delivering innovative solutions through prescription medicines, biologic therapies, vaccines, and animal health products.
Company Leadership NM
RS
GO
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BG
NP
NC
Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.
Company Leadership AN
KM
IE
WT
Founded in 2004, Corona Remedies is headquartered in Thaltej, Gujarat. They are a pharmaceutical manufacturing company.
Company Leadership BS
ST
Frequently Asked Questions Regarding Roche Top Executives and Leadership Team
Unlock more people and company data
